US, Canada expect Medical Device Single Audit Program draft guidelines this month
This article was originally published in Clinica
The US Department of Commerce has released an annual work plan that outlines the ongoing efforts between the US and Canada to align their medical device regulations. Among the initiatives, the governments are working together on finalizing Medical Device Single Audit Program (MDSAP) guidances and draft versions of these are expected to be delivered in June.
You may also be interested in...
FDA action awaits Sun’s manufacturing facility in Halol after it failed to adequately address GMP deviations, though India’s top-ranked drug firm appears to have effectively lowered its dependence on the site that has had a patchy compliance run.
In a surprise to the market, Dr Reddy’s and Hikma have prevailed in challenging six method-of-use patents shielding Amarin’s Vascepa in the US, opening the door for a potential at-risk launch that would likely be challenged by the originator.
Duo will study up to four novel preclinical targets identified by Sitryx that may lead to potential new drugs for autoimmune diseases, which Lilly would then commercialize.